Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study

Overview of attention for article published in Globalization and Health, September 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 2 policy sources

twitter: 6 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 58 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Global Pipeline of Innovative Medicinal Products: A Narrative Review

Article in The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation (February 2024)

A note on disease burden and pharmaceutical R&D

Article in Australian Economic Papers (May 2023)

Design of an adaptive randomized clinical trial of intravenous citrulline for sickle cell pain crisis in the emergency department

Article in Contemporary Clinical Trials Communications (January 2023)